The insulin receptor substrate-4 (IRS-4) gene and schizophrenia: No evidence for a main genetic factor, however one report of a single schizophrenia patient with a mutation

Neuroendocrinology Letters

Volumn 32, Issue 1, 2011, Pages 51-58

  Melkersson, Kristina ^a   Persson, Bengt ^a   Hongslo, Thorbjörn ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b NATIONAL VETERINARY INSTITUTE   (Sweden)

Author keywords

Case control study; DNA sequencing; IRS 4; Mutation; Schizophrenia; Single nucleotide polymorphism

Indexed keywords

ALANINE; ARGININE; ASPARAGINE; ASPARTIC ACID; CYSTEINE; GLYCINE; HISTIDINE; INSULIN RECEPTOR SUBSTRATE; INSULIN RECEPTOR SUBSTRATE 4; ISOLEUCINE; LEUCINE; LYSINE; PROLINE; SERINE; THREONINE; TYROSINE; UNCLASSIFIED DRUG; VALINE; IRS4 PROTEIN, HUMAN;

ADULT; ALLELE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARANOID SCHIZOPHRENIA; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; POINT MUTATION;

ADULT; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INSULIN RECEPTOR SUBSTRATE PROTEINS; MALE; MIDDLE AGED; POINT MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA;

EID: 79955033386     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Almind K, Frederiksen SK, Ahlgren MG, Urhammer S, Hansen T, Clausen JO, et al (1998). Common amino acid substitutions in insulin receptor substrate-4 are not associated with type II diabetes mellitus or insulin resistance. Diabetologia. 41: 969-974. (Pubitemid 28365985)
2. th ed. Washington DC: American Psychiatric Press.
3. Baruch K, Silberberg G, Aviv A, Shamir E, Bening-Abu-Shach U, Baruch Y, et al (2009). Association between golli-MBP and schizophrenia in the Jewish Ashkenazi population: are regulatory regions involved? Int J Neuropsychopharmacol. 12: 885-894.
4. Björnholm M, He AR, Attersand A, Lake S, Liu SCH, Lienhard GE, et al (2002). Absence of functional insulin receptor substrate-3 (IRS-3) gene in humans. Diabetologia. 45: 1697-1702. (Pubitemid 35478139)
5. Bonvicini C, Gennarelli M, Scassellati C, Bignotti S, Gardella R, Barlati S, et al (2010). Polymorphic CA repeat in IGF-1 gene: lack of association with schizophrenia. Psychiatr Genet. 20: 44-45.
6. Chiba T, Inoue D, Mizuno A, Komatsu T, Fujita S, Kubota H, et al (2009). Identification and characterization of an insulin receptor substrate 4-interacting protein in rat brain: implications for longevity. Neurobiol Aging. 30: 474-482.
7. Chumakov I, Blumenfeld M, Guerassimenko O, Cavarec L, Palicio M, Abderrahim H, et al (2002). Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proc Natl Acad Sci USA. 99: 13675-13680. (Pubitemid 35215440)
8. Craddock N, O'Donovan MC, Owen MJ (2005). The genetics of schizophrenia and bipolar disorder: dissecting psychosis [review]. J Med Genet. 42: 193-204. (Pubitemid 40380298)
9. Crow TJ (2007). How and why genetic linkage has not solved the problem of psychosis: review and hypothesis. Am J Psychiatry. 164: 13-21.
10. De Hert M, Steemans D, Theys P, Fryns J-P, Peuskens J (1996). Lujan-Fryns syndrome in the differential diagnosis of schizophrenia. Am J Med Genet. 67: 212-214.
11. 108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA. 98: 6917-6922. (Pubitemid 32538317)
12. Fantin VR, Sparling JD, Slot JW, Keller SR, Lienhard GE, Lavan BE (1998). Characterization of insulin receptor substrate 4 in human embryonic kidney 293 cells. J Biol Chem. 24: 10726-10732. (Pubitemid 28227688)
13. Fantin VR, Wang Q, Lienhard GE, Keller SR (2000). Mice lacking insulin receptor substrate 4 exhibit mild defects in growth, reproduction, and glucose homeostasis. Am J Physiol Endocrinol Metab. 278: E127-E133. (Pubitemid 30101929)
14. Faraone SV, Seidman LJ, Kremen WS, Toomey R, Pepple JR, Tsuang MT (2000). Neuropsychologic functioning among the nonpsychotic relatives of schizophrenic patients: the effect of genetic loading. Biol Psychiatry. 48: 120-126. (Pubitemid 30618801)
15. Flyckt LK (2001). Schizophrenia as a systemic disorder - studies of peripheral and central biological functions [dissertation]. Stockholm, Sweden: Karolinska Institutet.
16. Goren HJ, Kulkarni RN, Kahn R (2004). Glucose homeostasis and tissue transcript content of insulin signaling intermediates in four inbred strains of mice: C57BL/6, C57BLKS/6, DBA/2, and 129X1. Endocrinology. 145: 3307-3323. (Pubitemid 38830003)
17. Gottesman II, Shields J (1967). A polygenic theory of schizophrenia. Proc Natl Acad Sci USA. 58: 199-205.
18. Green EK, Grozeva D, Jones I, Jones L, Kirov G, Caesar S, et al (2009). The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia. Mol Psychiatry. 15: 1016-1022.
19. Gunnell D, Lewis S, Wilkinson J, Georgieva L, Smith Davey G, Day INM, et al (2007). IGF1, growth pathway polymorphisms and schizophrenia: a pooling study. Am J Med Genet. 144B: 117-120. (Pubitemid 46122648)
20. Hanauer A, Young ID (2002). Coffin-Lowry syndrome: clinical and molecular features [review]. J Med Genet. 39: 705-713. (Pubitemid 35178719)
21. http://www.ensembl.org/ (release 46, August 2007).
22. http://www.ncbi.nlm.nih.gov/(version 31.08.2007).
23. th ed. New York: Lippincott Williams &Wilkins. p.145-168.
24. Lavan BE, Fantin VR, Chang ET, Lane WS, Keller SR, Lienhard GE (1997). A novel 160-kDa phosphotyrosine protein in insulin-treated embryonic kidney cells is a new member of the insulin receptor substrate family. J Biol Chem. 272: 21403-21407. (Pubitemid 27374010)
25. th ed. New York: Lippincott Williams & Wilkins. p.169-178.
26. Melkersson K (2009). Familial and sporadic schizophrenia: a comparison of somatic diseases and abuse in patients and their relatives. Acta Neuropsychiatr. 21: 4-10.
27. Melkersson K, Hulting A-L (2009). Serotonin receptor 2A gene polymorphisms and schizophrenia: association with family history, diagnostic subtype and height in patients. Neuroendocrinol Lett. 30: 343-351.
28. Meltzer HY (1976). Neuromuscular dysfunction in schizophrenia [review]. Schizophr Bull. 2: 106-136.
29. Nilsson BM, Forslund AH, Olsson RM, Hambraeus L, Wiesel F-A (2006). Differences in resting energy expenditure and body composition between patients with schizophrenia and healthy controls. Acta Psychiatr Scand. 114: 27-35. (Pubitemid 43885482)
30. Numan S, Russell DS (1999). Discrete expression of insulin receptor substrate-4 mRNA in adult rat brain. Brain Res Mol Brain Res. 72: 97-102.
31. Nyegaard M, Demontis D, Foldager L, Hedemand A, Flint TJ, Sorensen KM, et al (2010). CACNA1C (rs1006737) is associated with schizophrenia. Mol Psychiatry. 15: 119-121.
32. O'Donovan MC, Craddock N, Norton N, Williams H, Peirce T, Moskvina V, et al (2008). Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet. 40: 1053-1055.
33. Perrin MA, Chen H, Sandberg DE, Malaspina D, Brown AS (2007). Growth trajectory during early life and risk of adult schizophrenia. Br J Psychiatry. 191: 512-520. (Pubitemid 350273212)
34. Reiss AL, Hagerman RJ, Vinogradov S, Abrams M, King RJ (1988). Psychiatric disability in female carriers of the fragile X chromosome. Arch Gen Psychiatry. 45: 25-30.
35. Ross MT, Grafham DV, Coffey AJ, Scherer S, McLay K, Muzny D, et al (2005). The DNA sequence of the human X chromosome. Nature. 434: 325-337. (Pubitemid 40469169)
36. rd ed. New York: Lippincott Williams & Wilkins. p.207-223.
37. Rujescu D, Ingason A, Cichon S, Pietiläinen OPH, Barnes MR, Toulopoulou T, et al (2009). Disruption of the neurexin 1 gene is associated with schizophrenia. Hum Mol Genet. 18: 988-996.
38. Ryan MCM, Collins P, Thakore JH (2003). Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. Am J Psychiatry. 160: 284-289. (Pubitemid 41110453)
39. Sara VR, Hall K, von Holtz H, Humbel R, Sjögren B, Wetterberg L (1982). Evidence for the presence of specific receptors for insulin-like growth factors 1 (IGF-1) and 2 (IGF-2) and insulin throughout the adult human brain. Neurosci Lett. 34: 39-44. (Pubitemid 13093631)
40. Stefansson H, Ophoff RA, Steinberg S, Andreassen OA, Cichon S, Rujescu D, et al (2009). Common variants conferring risk of schizophrenia. Nature. 460: 744-747.
41. Stefansson H, Sigurdsson E, Steinthorsdottir V, Bjornsdottir S, Sigmundsson T, Ghosh S, et al (2002). Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet. 71: 877-892.
42. Stephens M, Scheet P (2005). Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation. Am J Hum Genet. 76: 449-462. (Pubitemid 40250525)
43. Stephens M, Smith NJ, Donnelly P (2001). A new statistical method for haplotype reconstruction from population data. Am J Hum Genet. 68: 978-989. (Pubitemid 32289743)
44. Straub RE, Jiang Y, MacLean CJ, Ma Y, Webb BT, Myakishev MV, et al (2002). Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am J Hum Genet. 71: 337-348. (Pubitemid 34800250)
45. Szpak GM, Lewandowska E, Schmidt-Sidor B, Popow J, Kozlowski P, Lechowicz W, et al (1996). Adult schizophrenic-like variant of adrenoleukodystrophy. Folia Neuropathol. 34: 184-192.
46. Wiesel FA (2007). Schizophrenia is a systemic disease. Genetic mechanisms and environmental factors interact in the disease development [in Swedish]. Lakartidningen. 104: 2146-2147.
47. Vita A, Dieci M, Silenzi C, Tenconi F, Giobbio GM, Invernizzi G (2000). Cerebral ventricular enlargement as a generalized feature of schizophrenia: a distribution analysis on 502 subjects. Schizophr Res. 44: 25-34. (Pubitemid 30365204)
48. Wozniak M, Rydzewski B, Baker SP, Raizada MK (1993). The cellular and physiological actions of insulin in the central nervous system. Neurochem Int. 22: 1-10.
49. Ye P, Li L, Lund PK, D'Ercole AJ (2002). Deficient expression of insulin receptor substrate-1 (IRS-1) fails to block insulin-like growth factor-1 (IGF-1) stimulation of brain growth and myelination. Brain Res Dev Brain Res. 136: 111-121. (Pubitemid 34718117)